Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome

Irmgard Mühlberger1, Konrad Moenks, Andreas Bernthaler

  • 1Emergentec Biodevelopment GmbH, Gersthofer Strasse 29-31, 1180 Vienna, Austria.

Insights

Cardiorenal syndrome links kidney and heart disease. Researchers identified 280 molecular factors, revealing key pathways like endothelin and VEGF signaling, offering potential new therapeutic targets for cardiorenal disease.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Molecular Biology
  • Systems Biology

Background:

  • Cardiorenal syndrome is the co-occurrence of kidney and cardiovascular diseases.
  • Cardiovascular events are the leading cause of mortality in patients with chronic kidney disease.
  • Molecular analyses reveal cross-talk between cardiovascular and kidney disease pathologies.

Purpose of the Study:

  • To comprehensively identify molecular factors involved in the cardiorenal syndrome.
  • To analyze molecular processes and pathways underlying the bidirectional interplay between kidney and cardiovascular systems.
  • To uncover potential novel therapeutic targets for cardiorenal syndrome.

Main Methods:

  • Systematic literature mining for molecular features associated with cardiorenal syndrome.
  • Identification of 280 unique genes/proteins.
  • Analysis of molecular processes and pathways using protein interaction networks.
  • Integrated analysis of identified features.

Main Results:

  • Identified 280 unique genes/proteins implicated in cardiorenal syndrome.
  • Found well-established renin-angiotensin system features and numerous signal transduction/cell communication proteins.
  • Discovered a protein interaction network involving hemodynamic mediators.
  • Highlighted involvement of endothelin and VEGF signaling pathways.

Conclusions:

  • The study identified a comprehensive set of molecular features contributing to cardiorenal syndrome.
  • Protein interaction network analysis revealed key pathways like endothelin and VEGF signaling.
  • Several identified molecular features represent potential novel therapeutic targets for cardiorenal syndrome.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...